Atea Pharmaceuticals, Inc. Common Stock (NASDAQ: AVIR) last traded at $5.15, down 0.10% on the session. The quote above updates while this page is open; the figures below are drawn from Atea Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Atea Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker AVIR. Its market capitalisation is $413.05 million.
Valuation measures for Atea Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $413.05M |
|---|---|
| Enterprise value | $376.29M |
| Price / book | 2.02 |
| Beta | 0.72 |
Trailing-twelve-month figures tagged in Atea Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$165.29M |
| EPS (TTM) | -$2.08 |
|---|
| Return on equity | -80.96% |
|---|
| Cash | $76.55M |
|---|
Range and volume for AVIR over the past 52 weeks.
| 52-week high | $6.45 |
|---|---|
| 52-week low | $2.87 |
| Volume | 158.0K |
| Average volume | 296.8K |
| Previous close | $5.16 |
Invest a chosen dollar amount in Atea Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AVIR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.